Jim Simons’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,211,604
| Closed | -$254K | – | 3840 |
|
|
2018
Q3 | $254K | Buy |
1,211,604
+133,200
| +12% | +$30.7K | ﹤0.01% | 3071 |
|
|
2018
Q2 | $280K | Buy |
1,078,404
+56,300
| +6% | +$14.6K | ﹤0.01% | 2988 |
|
|
2018
Q1 | $256K | Buy |
1,022,104
+431,500
| +73% | +$119K | ﹤0.01% | 3124 |
|
|
2017
Q4 | $187K | Sell |
590,604
-89,800
| -13% | -$30.6K | ﹤0.01% | 3148 |
|
|
2017
Q3 | $254K | Buy |
680,404
+548,800
| +417% | +$267K | ﹤0.01% | 2943 |
|
|
2017
Q2 | $112K | Buy |
131,604
+14,800
| +13% | +$24.2K | ﹤0.01% | 3079 |
|
|
2017
Q1 | $371K | Buy |
116,804
+19,200
| +20% | +$50.1K | ﹤0.01% | 2853 |
|
|
2016
Q4 | $200K | Buy |
97,604
+40,666
| +71% | +$129K | ﹤0.01% | 3006 |
|
|
2016
Q3 | $269K | Buy |
56,938
+20,625
| +57% | +$133K | ﹤0.01% | 2990 |
|
|
2016
Q2 | $334K | Sell |
36,313
-607
| -2% | -$6.24K | ﹤0.01% | 2919 |
|
|
2016
Q1 | $428K | Buy |
36,920
+1,740
| +5% | +$19.6K | ﹤0.01% | 2884 |
|
|
2015
Q4 | $500K | Buy |
35,180
+5,645
| +19% | +$93.3K | ﹤0.01% | 2738 |
|
|
2015
Q3 | $496K | Sell |
29,535
-13,032
| -31% | -$237K | ﹤0.01% | 2633 |
|
|
2015
Q2 | $804K | Buy |
42,567
+31,417
| +282% | +$605K | ﹤0.01% | 2554 |
|
|
2015
Q1 | $216K | Buy |
11,150
+8,542
| +328% | +$214K | ﹤0.01% | 2865 |
|
|
2014
Q4 | $76K | Buy |
+2,608
| New | +$75.1K | ﹤0.01% | 2834 |
|
Other funds holding IMUC
Jim Simons's IMUC Position: Q4 2018 in Review
Jim Simons sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 1,211,604 shares — an estimated $254K sold.
Jim Simons first reported a position in IMUC in Q4 2014 and held it in 16 quarters. The position peaked at $804K in Q2 2015. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.
- Jim Simons reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
- Jim Simons sold 1,211,604 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018, an estimated $254K.
- Jim Simons first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2014 and held it in 16 quarters.
- Jim Simons's ImmunoCellular Therapeutics, Ltd. position peaked at $804K in Q2 2015.
- 3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.